These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. On the treatment of vitiligo. el Mofty AM; Nada MM Int J Dermatol; 1971; 10(4):262-6. PubMed ID: 5114016 [No Abstract] [Full Text] [Related]
9. Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease. Plettenberg H; Assmann T; Ruzicka T Arch Dermatol; 2003 May; 139(5):651-4. PubMed ID: 12756103 [No Abstract] [Full Text] [Related]
10. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Halder RM; Battle EF; Smith EM Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934 [No Abstract] [Full Text] [Related]
11. Ineffectiveness of trioxsalen as an oral photosensitizer. Kligman AM; Goldstein FP Arch Dermatol; 1973 Mar; 107(3):413-4. PubMed ID: 4692130 [No Abstract] [Full Text] [Related]
12. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo. Parsad D; Kanwar AJ; Kumar B J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626 [TBL] [Abstract][Full Text] [Related]
14. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo. Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265 [TBL] [Abstract][Full Text] [Related]
15. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887 [TBL] [Abstract][Full Text] [Related]
16. Some biochemical and chemotherapeutic aspects of vitiligo. Chakraborty DP Indian J Dermatol; 1966 Apr; 11(3):69-75. PubMed ID: 5945820 [No Abstract] [Full Text] [Related]
17. Childhood vitiligo: a prospective hospital-based study. Al-Mutairi N; Sharma AK; Al-Sheltawy M; Nour-Eldin O Australas J Dermatol; 2005 Aug; 46(3):150-3. PubMed ID: 16008644 [TBL] [Abstract][Full Text] [Related]
18. [Treatment acquired vitiligo with Beroxan]. Rudowska I Przegl Dermatol; 1969; 56(2):225-9. PubMed ID: 5790582 [No Abstract] [Full Text] [Related]
19. [Experience with Meladinin treatment of patients with vitiligo]. Shalupenko VN Vrach Delo; 1966 Aug; 8():139-40. PubMed ID: 5989145 [No Abstract] [Full Text] [Related]
20. [Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?]. Marcet B; Sibaud V; Géniaux M; Taieb A Ann Med Interne (Paris); 2002 Sep; 153(5):349-50. PubMed ID: 12442082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]